Answers are grounded in this paper and cite their sources.
In vitro study reveals that simulated microgravity triggers HIF-1-driven glycolytic reprogramming in breast cancer cells, highlighting mechanical control of tumor metabolism.
With the expansion of commercial spaceflight and space exploration, the microgravity environment provides unparalleled opportunities to fight against challenging diseases. Here, we investigate the impact of simulated microgravity (sMG) on the cellular morphology and metabolic state of triple-negative breast cancer (TNBC). TNBC cells (SUM159 and MDA-MB-231) were exposed to sMG (~0.001 g) using a random positioning machine (RPM) for 1 and 3 days. Transcriptome profiling revealed that sMG induced a hypoxic-like state, characterized by altered expression of genes typically associated with hypoxia, even under standard aerated incubator conditions. Mechanistically, sMG upregulated HIF-1α protein levels and its target gene expression, and downregulated c-MYC and its target gene expression. In addition, sMG mediated metabolic reprogramming of TNBC cells by shifting the metabolic flux toward glycolysis and away from glutaminolysis and TCA cycle. Metabolomic analysis further confirmed activation of the glycolytic pathway under sMG. Our findings demonstrate that sMG induces a HIF-1-mediated hypoxic-like and glycolytic state in TNBC cells, implicating a gravity-responsive HIF-1/c-MYC coordinated module in mechanotransductive metabolic control.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: